Company: ARTL
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001640334-25-001429
Chunk: 399

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 399
---
 General and administrative      Employee and director compensation $232  $230 Stock-based compensation  86   134 Professional fees  712   163 Other general and administrative (a)  249   300 Total general and administrative  1,279   827    Six Months ended   June 30,   2025  2024        General and administrative      Employee and director compensation $471  $474 Stock-based compensation  200   273 Professional fees  1,037   553 Other general and administrative (a)  566   609 Total general and administrative  2,274   1,909    Three months ended   June 30,   2025  2024        Research and development      Employee compensation $243  $239 Stock-based compensation  65   61 Professional fees  2,194   1,373 Other research and development (b)  (631)  12 Total research and development  1,871   1,685    Six Months ended   June 30,   2025  2024        Research and development      Employee compensation $476  $468 Stock-based compensation  143   135 Professional fees  3,204   2,346 Other research and development (b)  (568)  243 Total research and development  3,255   3,192  (a)Consists of sales and marketing, investor relations, travel and other office expenses.  (b)Consists of supplies and other items used in research and development activities.

 12Table of Contents

NOTE 4 – RELATED PARTY TRANSACTIONS During the six months ended June 30, 2025, and 2024, a company owned by the Senior Vice President, European Operations, provided consulting services totaling $11 and $4, respectively. As of June 30, 2025, and December 31, 2024, there was $1 and $1, outstanding, respectively. During the six months ended June 30, 2025, and 2024, a company significantly influenced by a director of a subsidiary of the Company provided professional services totaling $55 and $74, respectively. As of June